April 24th Pharma Day – Second Edition. The day to make best practice in science-industry cooperation.
The second edition of Pharma Day gathered – again! – extraordinary people committed to develop excellence in science and to turn it into life application. All of that to move forward to clinical practice and to help patients. We had excellent speeches, great discussions and what is the most important – new contacts that will […] ›
Jagodziński TRIO Concert
Sorry, this entry is only available in Polski. ›
21.05.2015 g.21.20: dr Karolina Dzwonek, BASTION innovation manager talks to Karolina Głowacka on Radio TOK FM
Sorry, this entry is only available in Polski. ›
BASTION workshop
Sorry, this entry is only available in Polski. ›
Prof. Jakub Gołąb for hematoonkologia.pl
Professor Jakub Golab ( MUW ) of the BASTION Project in an interview for the hematoonkologia.pl poratl talked about cancer immunotherapy . Professor Jakub Golab: “I regret that in Poland there is no university course of study related medical chemistry . We don’t have a sufficient number of specialists in this country, a few we have […] ›
Dr. Pawel Gaj and dr. Radoslaw Zagozdzon published a research letter in the Breast Cancer Research journal on the clinical relevance of miR-510 in breast cancer
A Breast Cancer Research journal letter “In silico analysis of microRNA-510 as a potential oncomir in human breast cancer” has been published on March 12th 2014. The authors provide the context of -omics type population-centered in silico analysis to discuss a previously published information on a putative oncogenic character of miR-510 effects. The published results […] ›
Interview with prof. J. Golab and prof. S. Majewski [VIDEO]
Sorry, this entry is only available in Polski. ›
Cancer genetics for medical community Workshop organized by the Medical University of Warsaw in the project BASTION – photo gallery
Sorry, this entry is only available in Polski. ›
The latest paper of prof Jakub Golab MD, PhD on the antitumor effect of photodynamic therapy
On February 18th in European Journal of Cancer (EJC) an articleentitled 5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy has been published. The study was focused on antitumor effect of photodynamic therapy combined with 5-aza-2’-deoxycytidine, a methyltransferase inhibitor. Our observation suggest that clinically approved epigenetic agent 5-aza-2’-deoxycytidine can improve PDT induced antitumor immune response leading to […] ›
Basic Information on IMI initiative [VIDEO]
The video made by: www.openmedica.pl ›